EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modelling of a double‐scattering proton therapy nozzle using the FLUKA Monte Carlo code and analysis of linear energy transfer in patients treated for prostate cancer

Rasmus Klitgaard iD, Lars Fredrik Fjæra, Camilla Hanquist Stokkevåg, Perry Johnson, Mark Artz, Nancy Price Mendenhall, Curtis Bryant, Ludvig Paul Muren

Journal of Applied Clinical Medical Physics · 2025

DOI: 10.1002/acm2.70032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2025. Verfasst von Rasmus Klitgaard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Danish Centre for Particle Therapy, Aarhus University, Aarhus N, Denmark. Hauptthemen laut MEDLINE: Monte Carlo Method, Prostatic Neoplasms, Proton Therapy, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The dose‐averaged linear energy transfer (LET D ) in proton therapy (PT) has in pre‐clinical studies been linked to the relative biological effectiveness (RBE) of protons. Until recently, the most common PT delivery method in prostate cancer has been double‐scattered PT, with LET D only available through dedicated Monte Carlo (MC) simulations. However, as most studies of the relationship between LET D and RBE in double scattered PT have been focused on the head and neck region, existing MC implementations have not been capable of calculating LET D for the longer field ranges used, for example, in the pelvic region.

Purpose

The initial aim of this study was to implement a MC code allowing for LET D calculations in double‐scattered PT of prostate cancer. Additionally, we explored LET D profiles and LET D as a function of field configuration, by performing MC calculations for a large prostate cancer cohort treated with double‐scattered PT.

Methods

The components of a passive scattered clinical treatment nozzle used for delivery of extended field ranges, with two associated modulation wheels, were implemented into an existing FLUKA MC framework for LET D calculations. The code was validated to spread out Bragg peak (SOBP) measurements conducted using the treatment nozzle with 11 different range and modulation width configurations. After validation, LET D distributions were calculated on the planning computed tomographies of 582 prostate cancer patients treated with two‐field double‐scattered PT. All patients had symmetric field configurations with respect to the sagittal plane, with one pair of posterior oblique, lateral opposing, or anterior oblique fields. Dose and LET D volume parameters and the mean LET D ratio between the bladder and rectum were compared across the three groups.

Results

The range differences were below 1 mm for all SOBP scenarios used for calibration. For 9 of 11 SOBP scenarios, the modulation width differences were below 2 mm. For the patient simulations, the mean gamma pass rates (3 mm/3%) were at least 98% in the PTV, bladder, and rectum. Comparing anterior to posterior field configurations, the mean LET D in the bladder increased within both the 10 and 70 Gy iso‐dose regions, and conversely, the mean LET D decreased for the rectum. There was a marked difference in the mean bladder‐to‐rectum LET D ratios between anterior oblique, lateral opposing and posterior oblique field configurations.

Conclusion

A MC code allowing for accurate calculations of dose and LET D in double‐scattered PT of prostate cancer was implemented and validated. The LET D distributions in the rectum and bladder showed a systematic dependence on the field configuration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monte Carlo MethodProstatic NeoplasmsProton TherapyRadiotherapy Planning, Computer-AssistedLinear Energy TransferHumansMaleRadiotherapy DosageRelative Biological EffectivenessOrgans at RiskScattering, RadiationComputer SimulationRadiotherapy, Intensity-Modulated

Stichwörter der Autor:innen

FLUKAMonte Carlolinear energy transferprostate cancerproton therapy

Autor:innen und Institutionen

  • Danish Centre for Particle Therapy, Aarhus University, Aarhus N, Denmark.
  • Department of Medical Physics, Oslo University Hospital, Oslo, Norway.
  • Department of Physics and Technology, University of Bergen, Bergen, Norway.
  • Department of Radiation Oncology, College of Medicine, University of Florida Health, Jacksonville, Florida, USA.

ORCID-Profile: Rasmus Klitgaard

Zitieren

APA

Klitgaard, R., Fjæra, L. F., Stokkevåg, C. H., Johnson, P., Artz, M., Mendenhall, N. P., Bryant, C., & Muren, L. P. (2025). Modelling of a double‐scattering proton therapy nozzle using the FLUKA Monte Carlo code and analysis of linear energy transfer in patients treated for prostate cancer. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70032

Vancouver

Klitgaard R, Fjæra LF, Stokkevåg CH, Johnson P, Artz M, Mendenhall NP, et al. Modelling of a double‐scattering proton therapy nozzle using the FLUKA Monte Carlo code and analysis of linear energy transfer in patients treated for prostate cancer. Journal of Applied Clinical Medical Physics. 2025. doi:10.1002/acm2.70032

BibTeX
@article{Klitgaard2025,
  author = {Klitgaard, Rasmus and Fjæra, Lars Fredrik and Stokkevåg, Camilla Hanquist and Johnson, Perry and Artz, Mark and Mendenhall, Nancy Price and Bryant, Curtis and Muren, Ludvig Paul},
  title = {Modelling of a double‐scattering proton therapy nozzle using the FLUKA Monte Carlo code and analysis of linear energy transfer in patients treated for prostate cancer},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2025},
  doi = {10.1002/acm2.70032}
}
Kostenlos starten →